London
· Delayed Price · Currency is GBP · Price in EUR AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of GBP 99.77 million. The enterprise value is 108.08 million.
| Market Cap | 99.77M |
| Enterprise Value | 108.08M |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.19% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 21.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.10 |
| EV / Sales | 118.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -28.37 |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.22 |
| Interest Coverage | -7.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.16% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 22,934 |
| Profits Per Employee | -128,084 |
| Employee Count | 57 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.96% in the last 52 weeks. The beta is 1.19, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -42.96% |
| 50-Day Moving Average | 1.10 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 67.09 |
| Average Volume (20 Days) | 13,066 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of GBP 917,341 and -5.12 million in losses. Loss per share was -0.10.
| Revenue | 917,341 |
| Gross Profit | 699,451 |
| Operating Income | -6.92M |
| Pretax Income | -5.12M |
| Net Income | -5.12M |
| EBITDA | -7.28M |
| EBIT | -6.92M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 7.74 million in cash and 16.08 million in debt, giving a net cash position of -8.34 million.
| Cash & Cash Equivalents | 7.74M |
| Total Debt | 16.08M |
| Net Cash | -8.34M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -20.86M |
| Book Value Per Share | -0.35 |
| Working Capital | -2.67M |
Cash Flow
In the last 12 months, operating cash flow was -3.60 million and capital expenditures -212,803, giving a free cash flow of -3.81 million.
| Operating Cash Flow | -3.60M |
| Capital Expenditures | -212,803 |
| Free Cash Flow | -3.81M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 76.25% |
| Operating Margin | -754.25% |
| Pretax Margin | -557.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.19% |
| Shareholder Yield | -9.19% |
| Earnings Yield | -5.14% |
| FCF Yield | -3.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |